Search Results - "Pajic, Tadej"

The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms by Belčič Mikič, Tanja, Pajič, Tadej, Zver, Samo, Sever, Matjaž

“…mutations are a revolutionary discovery and represent an important hallmark of myeloproliferative neoplasms (MPN), especially essential thrombocythemia and…”
Get full text

Improved survival of AML patients by addition of cladribine to standard induction chemotherapy by Anžej Doma, Saša, Škerget, Matevž, Pajič, Tadej, Sever, Matjaž

“…One hundred and eight consecutive acute myeloid leukemia (AML) patients aged 60 or less treated with two different induction regimens were retrospectively…”
Get full text

Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry by Kralj, Eva, Trontelj, Jurij, Pajič, Tadej, Kristl, Albin

“…► Therapeutic drug monitoring is beneficial whilst using tyrosine kinase inhibitors. ► Dried blood spot (DBS) is a simple and less invasive blood sampling…”
Get full text

Factor V Leiden and FII 20210 testing in thromboembolic disorders by Pajič, Tadej

“…Factor V Leiden and prothrombin (F2) c.20210G>A mutation detection are very important in order to define the increased relative risk for venous thromboembolism…”
Get more information

Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein α with 13 years difference at onset by Debeljak, Maruša, Kitanovski, Lidija, Pajič, Tadej, Jazbec, Janez

Get full text

Identification of Variants Associated With Rare Hematological Disorder Erythrocytosis Using Targeted Next-Generation Sequencing Analysis by Kristan, Aleša, Pajič, Tadej, Maver, Aleš, Režen, Tadeja, Kunej, Tanja, Količ, Rok, Vuga, Andrej, Fink, Martina, Žula, Špela, Podgornik, Helena, Anžej Doma, Saša, Preložnik Zupan, Irena, Rozman, Damjana, Debeljak, Nataša

“…An erythrocytosis is present when the red blood cell mass is increased, demonstrated as elevated hemoglobin and hematocrit in the laboratory evaluation…”
Get full text

Utility of next-generation sequencing in identifying congenital erythrocytosis in patients with idiopathic erythrocytosis by Anžej Doma, Saša, Kraljić, Nika, Kristan, Aleša, Debeljak, Nataša, Maver, Aleš, Pajič, Tadej, Preložnik Zupan, Irena

“…Congenital erythrocytosis (CE) is increasingly recognized as the cause of erythrocytosis in patients in whom polycythemia vera and secondary acquired causes…”
Get full text

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis by Pajič, Tadej, Belčič Mikič, Tanja, Podgornik, Helena, Klun, Jurka, Šućurović, Sandra, Zver, Samo, Sever, Matjaz

“…High resolution melting analysis (HRM) is a powerful method for genotyping and genetic variation scanning. Most HRM applications depend on saturating DNA dyes…”
Get more information

Genetic analysis of 39 erythrocytosis and hereditary hemochromatosis‐associated genes in the Slovenian family with idiopathic erythrocytosis by Kristan, Aleša, Gašperšič, Jernej, Režen, Tadeja, Kunej, Tanja, Količ, Rok, Vuga, Andrej, Fink, Martina, Žula, Špela, Anžej Doma, Saša, Preložnik Zupan, Irena, Pajič, Tadej, Podgornik, Helena, Debeljak, Nataša

“…Background Erythrocytosis is a condition with an excessive number of erythrocytes, accompanied by an elevated haemoglobin and/or haematocrit value. Congenital…”
Get full text

Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings? by Belčič Mikič, Tanja, Vratanar, Bor, Pajič, Tadej, Anžej Doma, Saša, Debeljak, Nataša, Preložnik Zupan, Irena, Sever, Matjaž, Zver, Samo

“…, and mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative…”
Get full text

Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report by Doma, Saša Anžej, Hillarp, Andreas, Pajič, Tadej, Andoljšek, Dušan, Černelč, Peter, Preldžnik Zupan, Irena

“…Acquired inhibitors to coagulation factors other than factor VIII are extremely rare. We describe a case of a 59-year-old woman with abnormal bleeding,…”
Get full text

Monitoring of imatinib targeted delivery in human leukocytes by Kralj, Eva, Žakelj, Simon, Trontelj, Jurij, Pajič, Tadej, Preložnik Zupan, Irena, Černelč, Peter, Ostanek, Barbara, Marc, Janja, Kristl, Albin

“…[Display omitted] The success of imatinib therapy in chronic myeloid leukemia is highly influenced by its active transport into target cells. However, the…”
Get full text

Glutamate dehydrogenase activity in lymphocytes of B-cell chronic lymphocytic leukaemia patients by Pajič, Tadej, Černelč, Peter, Sešek Briški, Alenka, Lejko-Zupanc, Tatjana, Malešič, Ivan

“…Objectives: To investigate the pattern of glutamate dehydrogenase (GLDH) activity, GLUD1 and GLUD2 expressions in peripheral blood mononuclear cells (PBMC) of…”
Get full text

The thrombopoietin receptor W515L and W515k mutations detection in patients with essential thrombocythemia by Pajic, Tadej, Kovacic, Leonida, Mlakar, Uros

“…Background: The aim of the study was to investigate the frequency of the thrombopoietin receptor (MPL) W515L and W515K mutations in our cohort of essential…”
Get full text

Determination of D816V mutation in the c-kIt gene in the Slovenian patients with acute myeloid leukemia and systemic mastocytosis by Fink, Martina, Cernelc, Peter, Pajic, Tadej

“…Background: D816V mutation in the C-KIT gene is present in more than 90 % of patients with systemic mastocytosis (SM) and 2-7 % of patients with acute myeloid…”
Get full text

Risk factors for thromboembolic events in children and young adults by Kotnik, Barbara Faganel, Kitanovski, Lidija, Pajic, Tadej, Dolnicar, Majda Benedik

“…Background: Thromboembolic events (TEE) in children are rare. They develop through concomitant hemodynamic disturbances in the cardiovascular system or as a…”
Get full text

Identification of JAK2 exon 12 mutations in patients with polycythemia vera by Mandelc Mazaj, Marija Jedrt, Lozar, Sasenka, Cernelc, Peter, Pajic, Tadej

“…Background: Polycythemia vera (PV) is characterized by erythrocytosis and mutation in JAK2 gene. More than 95 % of patients with PV have somatic mutation JAK2…”
Get full text

Bcr-aBL1 kinase domain mutation analysis in chronic myeloid leukaemia patients with suboptimal response to tyrosine kinase inhibitors by Pajic, Tadej, Lamovsek, Nejc, Fink, Martina, Preloznik, Irena Zupan, Cernelc, Peter

“…Background: The acquired mutations in the BCR-ABL1 kinase domain (KD) may contribute to resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid…”
Get full text

MUTATIONAL STATUS OF REARRANGED IMMUNOGLOBULIN HEAVY CHAINVARIABLE GENES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA by Pajic, Tadej, Cernelc, Peter

“…BACKGROUND Mutational status of rearranged immunoglobulin heavy chain variable genes (IGHV)in leukaemia cells of patients with chronic lymphocytic leukaemia…”
Get full text

RESPONSE TO DESMOPRESSIN (DDAVP): PREOPERATIVE TESTING by Dušan Andoljšek, Tadej Pajič

“…BACKGROUND The principle of treatment or prevention of bleeding in von Willebrand disease (vWd)is correction of dual plasma deficiency of von Willebrand factor…”
Get full text